AMN Healthcare Services, Inc. AMN is still struggling with the normalization of nurse staffing post-pandemic. This Zacks Rank #5 (Strong Sell) is expected to see earnings decline another 61% this year. AMN Healthcare provides talent solutions for healthcare organizations across the nation. It's total talent solutions include managed services programs, clinical and interim healthcare leaders, temporary staffing, permanent placement, executive search, vendor management systems, recruitment process outsourcing, predictive modeling, language services, revenue cycle solutions and other services. Its clients include acute-care hospitals, community health centers and clinics, physician practice groups, retail and urgent care centers, home health facilities, schools and other healthcare settings. Another Beat in the First Quarter of 2024 On May 9, 2024, AMN Healthcare reported its first quarter results and beat on the Zacks Consensus Estimate by $0.04. Earnings were $0.97 versus the consensus of $0.93 for a 4.3% beat. It shouldn't be a surprise it beat again, as AMN Healthcare is an earnings all-star. It hasn't missed in 5 years. That kind of track record, which occurred during the Covid pandemic, is testament to the communication between AMN Healthcare's management and the analysts covering the company on Wall Street. Because business has been in quite the flux, despite the earnings beats. Yet management has been able to temper expectations. While first quarter revenue was in line with expectations, it still fell 27% year-over-year to $820.9 million. Earnings were down 61% from last year's quarter. It's largest segment, nursing staffing, still suffers from weaker demand and a continued competitive environment. In the quarter, revenue in the Nurse and Allied Solutions segment fell by 37% year-over-year to $519 million. That was also 3% lower than the fourth quarter of 2023 which indicates that the segment hasn't bottomed yet. Travel nurse staffing revenue fell by 44% compared to last year and 5% sequentially. Allied division revenue declined 13% year-over-year but was up 4% sequentially. One area of optimism was Language Services, up 16% year-over-year to $71 million and also up 4% sequentially. Is the worst over in Language Services? Analysts Continue to Cut 2024 Earnings Estimates AMN Healthcare issued a bleak outlook for the second quarter of 2024. It's no surprise that the analysts are doing the same but on the full year. 5 estimates have been cut in the last 60 days, pushing the 2024 earnings estimate down to $3.15 from $3.86. That's an earnings decline of 61.6% as AMN Healthcare made $8.21 last year. Zacks Investment Research Image Source: Zacks Investment Research Will Shares Roundtrip Back to the 2020 Lows? Shares of AMN Healthcare rallied big during the height of the pandemic in 2021 as travel nurses were in high demand at record high salaries. AMN Healthcare's earnings soared. But now we're on the flip side of that story, with the nursing demand still normalizing. The shares may yet retest the 2020 Covid lows. Zacks Investment Research Image Source: Zacks Investment Research Is it cheap? AMN Healthcare trades with a forward P/E of 15.4 as the earnings keep declining. While that is cheap, it's not dirt cheap. Investors should probably wait on the sidelines until it becomes clear that the nurse staffing revenue has stabilized. Watch the earnings estimates. When they start to be revised higher, that's when the outlook will be brighter. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report AMN Healthcare Services Inc (AMN):Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research
Bear of the Day: AMN Healthcare (AMN)
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...